Laboratory Corporation of America Holdings (LH)
$232.06 -$4.58 (-1.95%) 4:40 PM 12/11/24
NYSE | $USD | Diagnostics & ResearchStock Data
-
Market Cap
$19.45B -
Day's Range
$229.96 - $234.91 -
Volume
243,175 -
52 Week Low / High
$169.07 - $304.54 -
PE Ratio
44.05x -
PEG Ratio
0.50 -
Dividend Frequency
quarterly
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 10
- Strong Buy
- 2
- Buy
- 6
- Hold
- 0
- Sell
- 0
- Strong Sell
- $244.08
- Target Price
Company News
-
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...
-
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...
-
Labcorp Declares Quarterly Dividend — Oct 10th, 2024
BURLINGTON, N.C., Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 13,...
-
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock — Oct 14th, 2024
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens. The renowned laboratory service provider reported adjusted earnings of $3.94 in the last reported quarter, topping the Zacks Consensus Estimate by 4.23%. Labcorp...
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. — Oct 16th, 2024
First To Know® Syphilis Test With Box - Credit NOWDiagnostics (Photo: Business Wire) As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settings SPRINGDALE, Ark., October ...
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. — Oct 16th, 2024
First To Know® Syphilis Test With Box - Credit NOWDiagnostics (Photo: Business Wire) As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settings SPRINGDALE, Ark., October ...
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. — Oct 16th, 2024
First To Know® Syphilis Test With Box - Credit NOWDiagnostics (Photo: Business Wire) As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settings SPRINGDALE, Ark., October ...
-
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...
-
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock — Oct 14th, 2024
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens. The renowned laboratory service provider reported adjusted earnings of $3.94 in the last reported quarter, topping the Zacks Consensus Estimate by 4.23%. Labcorp...
-
Labcorp Declares Quarterly Dividend — Oct 10th, 2024
BURLINGTON, N.C., Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 13,...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. — Oct 16th, 2024
First To Know® Syphilis Test With Box - Credit NOWDiagnostics (Photo: Business Wire) As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settings SPRINGDALE, Ark., October ...
-
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test — Oct 10th, 2024
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C., Oct 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, ...
-
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...
-
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock — Oct 14th, 2024
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens. The renowned laboratory service provider reported adjusted earnings of $3.94 in the last reported quarter, topping the Zacks Consensus Estimate by 4.23%. Labcorp...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. — Oct 16th, 2024
First To Know® Syphilis Test With Box - Credit NOWDiagnostics (Photo: Business Wire) As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settings SPRINGDALE, Ark., October ...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. — Oct 16th, 2024
First To Know® Syphilis Test With Box - Credit NOWDiagnostics (Photo: Business Wire) As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settings SPRINGDALE, Ark., October ...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test — Oct 10th, 2024
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C., Oct 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, ...
-
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...
-
Labcorp Declares Quarterly Dividend — Oct 10th, 2024
BURLINGTON, N.C., Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 13,...
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. — Oct 16th, 2024
First To Know® Syphilis Test With Box - Credit NOWDiagnostics (Photo: Business Wire) As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settings SPRINGDALE, Ark., October ...
-
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock — Oct 14th, 2024
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens. The renowned laboratory service provider reported adjusted earnings of $3.94 in the last reported quarter, topping the Zacks Consensus Estimate by 4.23%. Labcorp...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
Labcorp Declares Quarterly Dividend — Oct 10th, 2024
BURLINGTON, N.C., Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 13,...
-
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock — Oct 14th, 2024
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens. The renowned laboratory service provider reported adjusted earnings of $3.94 in the last reported quarter, topping the Zacks Consensus Estimate by 4.23%. Labcorp...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
Labcorp Declares Quarterly Dividend — Oct 10th, 2024
BURLINGTON, N.C., Oct. 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on December 13,...
-
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...
-
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock — Oct 14th, 2024
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens. The renowned laboratory service provider reported adjusted earnings of $3.94 in the last reported quarter, topping the Zacks Consensus Estimate by 4.23%. Labcorp...
-
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...
-
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock — Oct 14th, 2024
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens. The renowned laboratory service provider reported adjusted earnings of $3.94 in the last reported quarter, topping the Zacks Consensus Estimate by 4.23%. Labcorp...
-
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock — Oct 14th, 2024
Labcorp Holdings Inc. LH, or Labcorp, is slated to report its third-quarter 2024 results on Oct. 24, before the market opens. The renowned laboratory service provider reported adjusted earnings of $3.94 in the last reported quarter, topping the Zacks Consensus Estimate by 4.23%. Labcorp...
-
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test — Oct 10th, 2024
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C., Oct 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, ...
-
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...
-
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test — Oct 10th, 2024
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C., Oct 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, ...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test — Oct 10th, 2024
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C., Oct 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, ...
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. — Oct 16th, 2024
First To Know® Syphilis Test With Box - Credit NOWDiagnostics (Photo: Business Wire) As syphilis cases surge nationwide, the collaboration will bring the First To Know® over-the-counter test to clinicians and patients across professional and hospital settings SPRINGDALE, Ark., October ...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
-
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors — Oct 18th, 2024
Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif., October 18, 2024--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointm...
-
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test — Oct 10th, 2024
Labcorp to serve as the exclusive NOWDiagnostics (NOWDx) distributor for clinical testing in the U.S., offering First to Know® Syphilis Test nationwide BURLINGTON, N.C., Oct 10, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, ...
-
Seeking Clues to Labcorp (LH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics — Oct 21st, 2024
Wall Street analysts expect Labcorp (LH) to post quarterly earnings of $3.49 per share in its upcoming report, which indicates a year-over-year increase of 3.3%. Revenues are expected to be $3.26 billion, up 6.7% from the year-ago quarter. The consensus EPS estimate for the quarter has be...
Portfolio
Comprised of 1 portfolios